Literature DB >> 29230114

Building a Phase 1 Cancer Research Program: Lessons Learned and Progress Made.

Marc R Matrana1,2, Julia Cook1.   

Abstract

Year:  2017        PMID： 29230114      PMCID： PMC5718442     

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  3 in total

1.  The ochsner cancer institute clinical trials program.

Authors:  Carl G Kardinal; Marilyn Bateman
Journal:  Ochsner J       Date:  2006

2.  Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.

Authors:  Shumei Kato; Vivek Subbiah; Razelle Kurzrock
Journal:  J Natl Compr Canc Netw       Date:  2017-07       Impact factor: 11.908

3.  Response rates, duration of response, and dose response effects in phase I studies of antineoplastics.

Authors:  D D Von Hoff; J Turner
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850
  3 in total
  1 in total

1.  Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN).

Authors:  Holly A Massett; Grace Mishkin; Jeffrey A Moscow; Amy Gravell; Michael Steketee; Martha Kruhm; Sae H Han; Barbara Barry; Michael Montello; James Zwiebel; Jeffrey S Abrams; James H Doroshow; S Percy Ivy
Journal:  Clin Cancer Res       Date:  2019-08-22       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.